Suspension of trading

ICAD Stock

ICAD

US44934S2068

Advanced Medical Equipment & Technology

Market Closed - Nasdaq 23:00:00 16/07/2025 +03			5-day change	1st Jan Change
3.870 ^USD	+3.75%		-.--%	-

21/07/25	ICAD, Inc.(NasdaqCM:ICAD) dropped from S&P TMI Index	CI
18/07/25	ICAD, Inc.(NasdaqCM:ICAD) dropped from Russell Microcap Value Benchmark Index	CI

Analysts' recommendations : ICAD

17/04/25	RadNet's iCAD Deal to Expand its Digital Health Services and Geographic Presence, Truist Says	MT
17/04/25	BTIG Research Downgrades iCAD to Neutral From Buy	MT
19/07/23	Lake Street Adjusts Price Target on icad to $5 From $2.50, Maintains Buy Rating	MT
13/04/23	JMP Securities Adjusts iCAD's Price Target to $4 From $7, Keeps Outperform Rating	MT
04/04/23	Oppenheimer Adjusts iCAD Price Target to $4 From $5, Maintains Outperform Rating	MT

More recommendations

News in other languages : ICAD

13/03/23	LA PREMIÈRE ÉTAPE DE L’OPÉRATION CONSISTE EN LA CESSION PAR ICAD…
26/04/21	CAC 40 : Les valeurs à suivre à Paris et en Europe
26/04/21	Les valeurs à suivre à Paris et en Europe (actualisé)
18/10/19	ICAD : annonce l’installation de la solution ProFound AI™ 2D pour la mammographie et pour la tomosynthèse (DBT) 3D au Centre d’Imagerie Paris Nord Sarcelles
25/01/19	Dow Jones Industrial Average : Wall Street attendue en hausse malgré Intel et les doutes sur la croissance

More news

Other Advanced Medical Equipment & Technology

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
ICAD	+3.75%	-.--%	-.--%	+77.52%	106M
THERMO FISHER SCIENTIFIC, INC.	+1.10%	-0.65%	+24.10%	+18.43%	225B
DANAHER CORPORATION	-0.19%	-3.62%	+2.55%	-20.00%	141B
INTUITIVE SURGICAL, INC.	+2.41%	+0.67%	-19.02%	+22.09%	130B
BOSTON SCIENTIFIC CORPORATION	-0.28%	-10.08%	-58.81%	-21.22%	62.29B
EDWARDS LIFESCIENCES CORPORATION	-2.77%	-6.15%	+8.15%	+12.69%	48.63B
SIEMENS HEALTHINEERS AG	-0.49%	-1.97%	-20.35%	-15.53%	49.39B
AGILENT TECHNOLOGIES, INC.	+2.66%	-2.61%	+15.94%	+29.91%	41.42B
WATERS CORPORATION	+1.67%	-0.25%	+35.01%	+55.09%	40.12B
RESMED, INC.	-0.60%	-4.41%	-20.52%	+44.06%	31.23B
Average	+0.73%	-3.08%	-3.29%	+20.30%	76.98B
Weighted average by Cap.	+0.52%	-2.50%	+0.60%	+9.85%

See all sector performances

iCAD Inc is a United Statesâ€‘based company. The Company develops artificial intelligence solutions designed to support healthcare providers in the detection and diagnosis of cancer. The company focuses on providing clinically proven AI technologies that assist medical professionals in identifying cancer earlier, improving diagnostic accuracy, and enhancing workflow efficiency. Its solutions include platforms for cancer detection, breast density assessment, and risk evaluation, enabling clinicians to analyze medical images and support patient care decisions. The company leverages advanced data, clinical evidence, and AIâ€‘driven technologies to deliver tools that integrate into existing healthcare systems and assist in screening and diagnostic processes across global markets.

Employees

Sector

Advanced Medical Equipment & Technology

More about the company

Stock Market
Stocks
ICAD Stock

40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!

SEIZE THE OFFER!

Market Cap	106M 90.98M 86.14M 78.08M 146M 10.09B 147M 1.02B 393M 5.13B 397M 388M 16.22B	P/E 2023	-9.35x	P/E 2024	-8.59x
Enterprise Value	88.75M 76.47M 72.4M 65.63M 123M 8.48B 124M 860M 331M 4.31B 333M 326M 13.63B	EV / Sales 2023	1.47x	EV / Sales 2024	1.6x
Free-Float	99.32%	Yield 2023 *	-	Yield 2024	-

08/07/25	ICAD Announces Proxy Advisory Firms ISS and Glass Lewis Recommend Stockholders Vote “FOR” Proposed Acquisition by RadNet, Inc.	AQ
04/06/25	ICAD INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of iCAD, Inc. - ICAD	BU
13/05/25	ICAD Reports Financial Results for First Quarter Ended March 31, 2025	AQ
29/04/25	ICAD Collaborates with Microsoft to provide access to its Mammography Solutions in Microsoft’s Precision Imaging Network (PIN)	AQ
17/04/25	ICAD INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of iCAD, Inc. - ICAD	BU

3 years	1.18	4.02
5 years	1.05	12.6
10 years	1.05	21.44

Manager	Title	Age	Since
Dana Brown CEO	Chief Executive Officer	61	10/03/2023
Mark Stolper DFI	Director of Finance/CFO	54	17/07/2025
Dave Katz SEC	Corporate Secretary	-	17/07/2025

Date	Insider	Type	Main position	Quantity	% Market Cap.
7/17/25 A	Andrew Sassine	Issuer sale	Director	1,553,657	5.8540%
7/17/25 A	Eric Lonnqvist	Issuer sale	Chief Financial Officer	158,488	0.5972%
7/17/25 A	Jonathan Go	Issuer sale	Chief Technology Officer	351,145	1.3231%

ICAD Stock

Stocks

ICAD

US44934S2068

Advanced Medical Equipment & Technology

Valuation : ICAD

Latest news : ICAD

Analysts' recommendations : ICAD

Press Releases : ICAD

News in other languages : ICAD

Quotes and Performance

Price Extremes

Managers and Directors : ICAD

Latest insider transactions

Other Advanced Medical Equipment & Technology

Financials

Company Profile

	2023	2024
Net sales	17.32M 14.92M 14.13M 12.81M 24.02M 1.65B 24.15M 168M 64.53M 842M 65.04M 63.61M 2.66B	19.61M 16.89M 16M 14.5M 27.2M 1.87B 27.34M 190M 73.06M 953M 73.64M 72.02M 3.01B
Net income	-4.85M -4.18M -3.95M -3.58M -6.72M -463M -6.76M -46.96M -18.06M -236M -18.2M -17.8M -744M	-5.62M -4.84M -4.58M -4.15M -7.79M -537M -7.83M -54.42M -20.93M -273M -21.09M -20.63M -863M
Net Debt	-21.21M -18.27M -17.3M -15.68M -29.42M -2.03B -29.57M -206M -79.02M -1.03B -79.65M -77.9M -3.26B	-16.84M -14.51M -13.74M -12.46M -23.37M -1.61B -23.49M -163M -62.76M -819M -63.26M -61.87M -2.59B